Meet the Team
Steering Committee
The work conducted by CF AMR Syndicate is overseen by a steering committee comprising people with CF, leading industry and academic experts in CF AMR, clinicians and representatives from the Medicines Discovery Catapult and Cystic Fibrosis Trust.
The steering committee is responsible for the development and delivery of the CF AMR Syndicate in AMR’s strategy. It provides on-going scientific advice and insights of people with CF on all Syndicate’s activities.
Dr Deborah O’Neil
(Chair)
Chief Executive Officer, NovaBiotics Ltd
Prof. Jane Davies
(Deputy Chair)
Professor in Paediatric Respirology & Experimental Medicine, National Heart and Lung Institute
Dr Richard Amison
Lecturer in Pharmacology, Scholl of Cancer and Pharmaceutical Science King’s College London
Prof. Miguel Camara
Professor of Molecular Microbiology, University of Nottingham & Co-Director, National Biofilm Innovations Centre
Dr. Victoria Savage
Head of Biology at Infex Therapeutics
Prof. Andres Floto
Professor of Respiratory Biology, University of Cambridge & Research Director at the Cambridge Centre for Lung Infection
Dr Jo Fothergill
Senior Lecturer Clinical Infection, Microbiology and Immunology, University of Liverpool
Abigail Halstead
People with CF
Dr Peter Jackson
Executive Director, Infex Therapeutics
Prof. Clive Page
Professor of Pharmacology, King’s College London & Director of the Sackler Institute of Pulmonary Pharmacology
Dr Mark Sutton
Scientific Leader, Public Health England
Laura Taylor
People with CF
Dr Christian Zwingelstein
Clinical Pharmacology, Antabio
Prof. Adilia Warris
Paediatric infectious disease specialist and Co-Director of the MRC Centre for Medical Mycology, University of Exeter
Pam Brown
Head of Chemistry, Centauri Therapeutics
Dr Yoann Personne
Director UK& Ireland Medical Affairs, bioMérieux
Management Team
The CF Syndicate in AMR is a partnership between Medicines Discovery Catapult and the Cystic Fibrosis Trust. Medicines Discovery Catapult (MDC) is a government-funded, not-for-profit organisation. It is enabling the community to reshape medicines discovery in the UK. The Trust is the only UK charity dedicated to fighting for a life unlimited by cystic fibrosis for everyone affected by the condition.
Day-to-day management of the Syndicate is carried out by:
Constance Takawira
Partnership Manager, Medicines Discovery Catapult
Dr Paula Sommer
Head of Research, Cystic Fibrosis Trust
Dr Beverley Isherwood
Partnership Lead, Medicines Discovery Catapult
Dr Lucy
Allen
Director of Research, Cystic Fibrosis Trust
Dr Catherine Kettleborough
Translational Challenge Leader – Associate Director, Drug Discovery Biology, LifeArc
Dr Kevin Buchan
Business Development Manager, LifeArc
Dr Ed McIver
Principal Scientist, LifeArc
